DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
DCPH
Delisted
DCPH was delisted on the 10th of June, 2024.
157 hedge funds and large institutions have $720M invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 49 increasing their positions, 55 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
9% less capital invested
Capital invested by funds: $792M → $720M (-$72.5M)
11% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 55
Holders
157
Holding in Top 10
2
Calls
$77K
Puts
$11K
Top Buyers
| 1 | +$12.6M | |
| 2 | +$4.13M | |
| 3 | +$3.92M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$2.99M |
| 5 |
Morgan Stanley
New York
|
+$2.83M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$5.13M | |
| 3 | -$3.95M | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$2.6M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$2.46M |